MedCity News

<img alt="" height="1" width="1" />
AstraZeneca bets on combinations in cancer immunotherapy race
LONDON (Reuters) - AstraZeneca is betting on drug combinations to help it catch up with industry leaders in the race to develop new treatments that harness the body&#39;s immune system to fight cancer. Bristol-Myers Squibb, Roche and Merck & Co are currently ...
AstraZeneca plc (ADR) (AZN): AstraZeneca well positioned to join cancer ...Seeking Alpha

all 6 news articles &raquo;